Ceftizoxime

• CAT Number: R023187
• CAS Number: 68401-81-0
• Molecular Formula: C₁₃H₁₃N₅O₅S₂
• Molecular Weight: 383.40
• Purity: ≥95%
• Synonyms: [6R-[6α,7β(Z)]]-7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; (6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-,5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyli
• Target: Bacterial
• Storage: -20°C
• IUPAC Name: (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• InChI: InChI=1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22)/b17-7-/t8-,11-/m1/s1
• InChIKey: NNULBSISHYWZJU-LLKWHZGFSA-N
• SMILES: CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O

Ceftizoxime（Cat No.:R023187）is a broad-spectrum third-generation cephalosporin antibiotic used to treat a variety of bacterial infections. It is effective against both Gram-positive and Gram-negative bacteria, including resistant strains. Ceftizoxime works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death. It is commonly used for infections of the respiratory tract, skin, urinary tract, and soft tissues. The compound is typically administered via intravenous or intramuscular injection. Ceftizoxime’s stability against beta-lactamases makes it a preferred option in cases of resistant bacterial infections. It is often used in hospital settings under medical supervision.